178 related articles for article (PubMed ID: 11756957)
21. Pemphigoid gestationis with predominant involvement of oral mucous membranes and IgA autoantibodies targeting the C-terminus of BP180.
Shimanovich I; Skrobek C; Rose C; Nie Z; Hashimoto T; Bröcker EB; Zillikens D
J Am Acad Dermatol; 2002 Nov; 47(5):780-4. PubMed ID: 12399776
[TBL] [Abstract][Full Text] [Related]
22. [Mucous membrane pemphigoid: IgG and IgA antibodies against the BP180 antigen].
España A; del Olmo J; Marquina M; Sitaru C
Actas Dermosifiliogr; 2005; 96(6):365-70. PubMed ID: 16476255
[TBL] [Abstract][Full Text] [Related]
23. The shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies in different blistering skin diseases.
Schumann H; Baetge J; Tasanen K; Wojnarowska F; Schäcke H; Zillikens D; Bruckner-Tuderman L
Am J Pathol; 2000 Feb; 156(2):685-95. PubMed ID: 10666397
[TBL] [Abstract][Full Text] [Related]
24. Linear IgA dermatosis with IgA and IgG autoantibodies to the 180 kDa bullous pemphigoid antigen (BP180): evidence for a distinct subtype.
Metz BJ; Ruggeri SY; Hsu S; Reed JA; Ghohestani AS; Uitto J; Ghohestani RF
Int J Dermatol; 2004 Jun; 43(6):443-6. PubMed ID: 15186228
[TBL] [Abstract][Full Text] [Related]
25. Linear IgA disease: the IgA and IgG response to the epidermal antigens demonstrates that intermolecular epitope spreading is associated with IgA rather than IgG antibodies, and is more common in adults.
Allen J; Wojnarowska F
Br J Dermatol; 2003 Nov; 149(5):977-85. PubMed ID: 14632802
[TBL] [Abstract][Full Text] [Related]
26. Molecular overlap of the IgA target antigens in the subepidermal blistering diseases.
Collier P; Wojnarowska F; Allen J; Kirtschig G
Dermatology; 1994; 189 Suppl 1():105-7. PubMed ID: 8049544
[TBL] [Abstract][Full Text] [Related]
27. Symmetrical Skin Lesions on the Gluteal Region in a Patient with Anti-Laminin-332 Mucous Membrane Pemphigoid.
Maki N; Demitsu T; Nagato H; Okada O; Yoneda K; Hashimoto T; Hasunuma N; Osada I; Manabe M
Acta Dermatovenerol Croat; 2021 Jul; 29(2):105-107. PubMed ID: 34477077
[TBL] [Abstract][Full Text] [Related]
28. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
[TBL] [Abstract][Full Text] [Related]
29. IgA autoantibodies in the pemphigoids and linear IgA bullous dermatosis.
Horváth B; Niedermeier A; Podstawa E; Müller R; Hunzelmann N; Kárpáti S; Hertl M
Exp Dermatol; 2010 Jul; 19(7):648-53. PubMed ID: 20500772
[TBL] [Abstract][Full Text] [Related]
30. Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol/L salt-split skin. Specificity, sensitivity, and practical considerations.
Lazarova Z; Yancey KB
J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):398-403. PubMed ID: 8784276
[TBL] [Abstract][Full Text] [Related]
31. Fc-binding proteins enhance autoantibody-induced BP180 depletion in pemphigoid.
Iwata H; Kamaguchi M; Ujiie H; Ujiie I; Natsuga K; Nishie W; Shimizu H
J Pathol; 2019 Mar; 247(3):371-380. PubMed ID: 30426510
[TBL] [Abstract][Full Text] [Related]
32. Integrin β4 is a major target antigen in pure ocular mucous membrane pemphigoid.
Li X; Qian H; Sogame R; Hirako Y; Tsuruta D; Ishii N; Koga H; Tsuchisaka A; Jin Z; Tsubota K; Fukumoto A; Sotozono C; Kinoshita S; Hashimoto T
Eur J Dermatol; 2016 Jun; 26(3):247-53. PubMed ID: 27193492
[TBL] [Abstract][Full Text] [Related]
33. Antiepiligrin cicatricial pemphigoid.
Hsu RC; Lazarova Z; Lee HG; Tung YC; Yu HS
J Am Acad Dermatol; 2000 May; 42(5 Pt 1):841-4. PubMed ID: 10775868
[TBL] [Abstract][Full Text] [Related]
34. Identification of a basement membrane zone antigen reactive with circulating IgA antibody in ocular cicatricial pemphigoid.
Smith EP; Taylor TB; Meyer LJ; Zone JJ
J Invest Dermatol; 1993 Oct; 101(4):619-23. PubMed ID: 8409534
[TBL] [Abstract][Full Text] [Related]
35. Study of original B cells producing pathogenic IgG and IgA autoantibodies in anti-BP180-type mucous membrane pemphigoid.
Hayashi D; Hashimoto T; Mine M; Ishii N; Hashimoto K; Tsuchisaka A; Tsuruta D
Arch Dermatol Res; 2024 May; 316(5):169. PubMed ID: 38734797
[No Abstract] [Full Text] [Related]
36. [Anti-p200 pemphigoid: Remission under mycophenolate mofetil (Cellcept®)].
Raffin D; Delaplace M; Roussel A; Estève E
Ann Dermatol Venereol; 2013 Dec; 140(12):784-7. PubMed ID: 24315224
[TBL] [Abstract][Full Text] [Related]
37. Childhood bullous pemphigoid: report of a case with characterization of the targeted antigens.
Trüeb RM; Didierjean L; Fellas A; Elias A; Borradori L
J Am Acad Dermatol; 1999 Feb; 40(2 Pt 2):338-44. PubMed ID: 10025864
[TBL] [Abstract][Full Text] [Related]
38. Desquamative gingivitis associated with IgG/IgA pemphigoid presents a challenging diagnosis and treatment: a case report.
Sánchez AR; Rogers RS; Kupp LI; Sheridan PJ
J Periodontol; 2004 Dec; 75(12):1714-9. PubMed ID: 15732876
[TBL] [Abstract][Full Text] [Related]
39. Autoantibodies from patients with cicatricial pemphigoid target different sites in epidermal basement membrane.
Shimizu H; Masunaga T; Ishiko A; Matsumura K; Hashimoto T; Nishikawa T; Domloge-Hultsch N; Lazarova Z; Yancey KB
J Invest Dermatol; 1995 Mar; 104(3):370-3. PubMed ID: 7861004
[TBL] [Abstract][Full Text] [Related]
40. Mucous membrane pemphigoid: a dual circulating antibody response with IgG and IgA signifies a more severe and persistent disease.
Setterfield J; Shirlaw PJ; Kerr-Muir M; Neill S; Bhogal BS; Morgan P; Tilling K; Challacombe SJ; Black MM
Br J Dermatol; 1998 Apr; 138(4):602-10. PubMed ID: 9640363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
